期刊文献+

自动化腹膜透析对常规腹膜透析患者合并急性心功能不全的治疗效果观察 被引量:6

Effect Observation of Automated Peritoneal Dialysis Treating Routine Peritoneal Dialysis Patients with Acute Heart Failure
下载PDF
导出
摘要 目的 分析研究自动化腹膜透析(automated peritoneal dialysis,APD)对已行腹膜透析的慢性肾脏病(chronic kidney disease,CKD)5期患者合并急性心功能不全的治疗效果及优缺点.方法 选择2015年6月—2017年2月收治的6例合并急性心功能不全的腹膜透析患者的临床资料,观察在应用APD治疗前后,患者心功能不全的症状、血清肌酐、血尿素氮(BUN)、血钾、脑利钠肽(BNP)、收缩压等指标的变化.结果 所有患者行APD治疗后心功能不全症状均明显改善.治疗后,患者血肌酐、BUN、BNP以及收缩压均显著低于治疗前,差异有统计学意义(P〈0.05).两组患者治疗前后血钾差异无统计学意义(P〉0.05).结论 对于腹膜透析患者,当其出现急性心功能不全时,APD治疗能够有效地改善急性心功能不全症状,增加超滤量,降低血肌酐、BUN、收缩压,同时可以避免临时置管风险,避免抗凝治疗出血风险. Objective To assess the efficacy, advantage, disadvantage of automated peritoneal dialysis (APD) for acute heart failure in patients who got peritoneal dialysis for the chronic kidney disease stage 5. Methods We collected the clinical data of 6 hospitalized patients with acute heart failure who got peritoneal dialysis from June 2015 to February 2017 and compared the changes of symptoms of heart failure, serum creatinine, urea nitrogen, serum potassium, plasma brain natriuretic peptide, systolic blood pressure before and after APD treatment. Results After treatment, the symptoms of acute heart failure were improved. Serum creatinine, urea nitrogen, plasma brain natriuretic peptide, systolic blood pressure were decreased (P〈0.05) after APD treatment. But serum potassium comparison showed no significant difference (P〉0.05). Conclusion For peritoneal dialysis patients with acute heart failure, APD can effectively improve the acute heart failure symptoms, increase the ultrafiltration, and reduce serum creatinine, blood urea nitrogen, systolic blood pressure. APD can also avoid the risk of temporary peritoneal dialysis catheter, and avoid the bleeding risk of anticoagulant therapy.
出处 《中国血液流变学杂志》 CAS 2017年第1期50-52,共3页 Chinese Journal of Hemorheology
关键词 自动化腹膜透析 慢性肾脏病5期 急性心功能不全 automatic peritoneal dialysis chronic renal disease stage 5 acute heart failure
  • 相关文献

参考文献6

二级参考文献54

  • 1陈凤锟,李冀军,陈璞,赵长征,龚红英,姚冬芳.高危出血风险患者无肝素透析后肝素盐水封管对凝血指标的影响[J].中国血液净化,2012,11(5):245-248. 被引量:17
  • 2李晓玫.慢性肾脏病基础上急性肾衰竭的诊断与防治[J].中华肾脏病杂志,2006,22(11):652-654. 被引量:55
  • 3王革,汤锋,杨丽南,余容琴.维持性血液透析患者下消化道出血的高危因素[J].西部医学,2007,19(1):44-45. 被引量:2
  • 4Biesen WV ,Yeys N, Vanholder N, et al. The role of APD in an ESRD program[J]. Seminars in Dialysis, 2002, 6: 422-426.
  • 5Li PK, Chow KM. Maximizing the success of peritoneal dialysis in hightransporters[J].Perit Dia Int, 2007,27: S148- S152.
  • 6Cueto-Manzano AM, Rojas-Campos E, Martinez-Ramirez HR, et al. Can the inflammation markers of patients with high Perito neal pemeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis[J]? Petit Dial lnt, 2006, 26:341-348.
  • 7Dives SJ, Woodrow G, Donovan K, et al. Icodextrin improves the fluid status of peritoneal dialysis patients:Results of a double-blind randomized controlled trial[J]. J Am Soc Nephrol ,2003, 14:2338-2344.
  • 8Finkelstein F, Healy H, Abu Alfa, Ahmad S , et al. Superiority of icodextrin compared with 4. 25% dextrose for peritoneal ultrafiltration[J].J Am Soc Nephrol, 2005,16:546 554.
  • 9Li PK, Cheng YL. Therapeutic options for presrvation of residual renal function in patients on peritoneal dialysis [J].Perit Dia Int , 2007,27:S158 -S163.
  • 10Rabindranath K S, Adams J, Ali T Z ,et al. Automated vs continuous ambulatory peritoneal dialysis a systematic review of randomized controlled trials[J]. Nephrol Dial Transplant, 2007,22: 2991-2998.

共引文献39

同被引文献38

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部